In an effort to develop therapeutic remedies for multiple sclerosis, scientists debate two possible interventional approaches – but they’re on opposite sides of the spectrum. Researchers at Wayne State University’s School of Medicine, however, have …
While cautioning that their findings still must be evaluated in humans, University of California, San Francisco and Stanford University Medical Center researchers report that the cholesterol-lowering drug atorvastatin (Lipitor) significantly improved, prevented relapses or reversed paralysis in mice with an experimental disease that closely resembles multiple sclerosis. The study, reported in the November 7 issue of Nature, was conducted in mice with experimental autoimmune encephalomyelitis (EAE), the standard animal model for multiple sclerosis.
